Fused allogenic peripheral blood DCs with SW620 CRC cells promoted significantly higher secretion of IFN-γ by CD8+ T cells and, when injected into highly immunodeficient CRLM mouse models, markedly reduced tumor growth compared to sham-vaccinated CRC cells [102]. The gene discussed is CD8A; the disease is colorectal carcinoma.